Piramal Enterprises Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Piramal Enterprises Limited
What Pharma CEOs, PEs Want To Move The Innovation Needle In India
Leaders of biopharma and private equity firms at a recent conference sought a robust domestic market and reimbursement mechanism to propel the innovation ecosystem in India, drawing parallels with the framework that aided China's ascent in the R&D value chain. Alongside, regulatory reform is also pivotal, they stressed.
Big Pharma Rescripts India Playbook
Big pharma appears to be resetting operations in India fueling some concerns of waning interest. In Vivo looks at what the realignment means or doesn’t.
Dissecting Piramal’s Damages Award In Sensipar Case
A legal expert details how Piramal Healthcare could turn the tables and secure damages in the litigation pertaining to its generic version of Amgen's Sensipar, a case which saw multiple at-risk launches.
Who’s Hired? Former Hikma Chief Olafsson Takes Lead At Mallinckrodt
Siggi Olafsson has taken the reins at Mallinckrodt after stepping down as Hikma’s CEO. At the same time, Teva has named a new global R&D and chief medical officer while Piramal Pharma Solutions has appointed a fresh COO and Formycon has added to its supervisory board.
- Generic Drugs
- Drug Discovery Tools
- Other Names / Subsidiaries
- Ash Stevens Inc.
- Life Molecular Imaging
- Piramal Critical Care
- Piramal Enterprises Ltd.
- Piramal Healthcare, Ltd.
- Piramal Imaging SA
- Piramal Life Sciences, Ltd.
- Piramal Pharma Solutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.